Christmas, CVS
Digest more
Scores of generic medicines produced in-house by pharmacy chain CVS have been recalled over the last decade after they were found to have been produced in unsanitary conditions, according to a ...
Zacks Investment Research on MSN
CVS Health (CVS) suffers a larger drop than the general market: Key insights
In the latest trading session, CVS Health (CVS) closed at $79.79, marking a -1.13% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 0.34% for the day. At the ...
CVS Health intentionally prevented certain Medicare beneficiaries from accessing less expensive, generic prescriptions, according to a whistleblower lawsuit from a former senior CVS executive.
John Pillaccio, accused in the fatal stabbing of a CVS employee on Long Island on Christmas Day, appeared before a judge on ...
Stocktwits on MSN
UnitedHealth, CVS, Molina get 2026 boost from ACA premiums rise — Mark Cuban slams insurers as 'too big to care'
The lapse of enhanced ACA subsidies has shifted more healthcare costs onto consumers, reshaping coverage dynamics in 2026.
The city is working with a contractor to finalize plans to tear down the vacant pharmacy that has been a magnet for problems ...
FOX 13 Tampa Bay on MSN
CVS store clerks pepper sprayed during St. Pete robbery, search underway for 2 suspects: Police
Investigators are searching for two suspects after CVS sales clerks were pepper-sprayed during a robbery in St. Petersburg ...
TipRanks on MSN
CVS Health price target raised to $91 from $87 at Bernstein
Bernstein raised the firm’s price target on CVS Health (CVS) to $91 from $87 and keeps a Market Perform rating on the shares.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback